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ABSTRACT. Objective: A single nucleotide variation in the alcohol 
dehydrogenase 1B (ADH1B) gene, rs1229984, produces an ADH1B 
enzyme with faster acetaldehyde production. This protective variant is 
associated with lower alcohol consumption and lower risk for alcohol 
use disorders (AUDs). Based on the premise that faster ADH1B kinetics 
decreases alcohol consumption, we formally tested if the association 
between ADH1B variant rs1229984 and AUDs occurs through consump-
tion. We also tested whether the association between rs1229984 and each 
of the 11 Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSM-IV), AUD criteria occurs through consumption. Method: 
A total of 1,130 lifetime drinkers from an Israeli household sample 
were assessed with a structured interview and genotyped for rs1229984 
(protective allele frequency = 0.28). Logistic regression evaluated the as-
sociation between rs1229984 and each phenotype (AUDs, 11 individual 
DSM-IV criteria). For phenotypes signifi cantly related to rs1229984, 
the effect through consumption was tested with logistic regression and 
bootstrapping. Results: ADH1B rs1229984 was signifi cantly associated 
with AUDs and six criteria, with odds ratios ranging from 1.32 to 1.96. 
The effect through consumption was signifi cant for these relationships, 
explaining 23%–74% of the total ADH1B effect. Conclusions: This is 
the fi rst study to show that ADH1B rs1229984 is related to 6 of the 11 
DSM-IV AUD criteria and that alcohol consumption explained a signifi -
cant proportion of these associations and the association of ADH1B with 
AUDs. Better understanding of the relationship between ADH1B and 
the DSM-IV AUD criteria, including effects through consumption, will 
enhance our understanding of the etiologic model through which AUDs 
can occur. (J. Stud. Alcohol Drugs, 75, 635–642, 2014)
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ALCOHOL USE DISORDERS (AUDs; alcohol depen-dence or abuse) are an important public health issue 
because of their substantial impact on physical and mental 
health (Rehm et al., 2009). Although many factors infl uence 
the risk of AUDs, the contribution of genetic factors is im-
portant. Alcohol dehydrogenase genes are among the most 
widely studied risk genes for AUDs (Rietschel and Treutlein, 
2013) because they determine the forms of the enzymes that 
convert alcohol (ethanol) to acetaldehyde during alcohol 
metabolism (Bosron et al., 1993; Thomasson et al., 1993).
 A single nucleotide polymorphism (SNP) in the alcohol 
dehydrogenase gene ADH1B (rs1229984) is signifi cantly as-
sociated with the risk for AUDs. This fi nding is particularly 
robust in East Asian populations in which the minor allele 
frequency is high (Li et al., 2011; Thomasson et al., 1991), 
but also signifi cant in European populations with lower to 
intermediate minor allele frequencies (Bierut et al., 2012; 
Meyers et al., 2013). Lower risk for AUD is found among 
individuals with the minor allele that encodes the more ac-
tive form of the enzyme. This form, producing faster con-
version of ethanol to acetaldehyde (Edenberg, 2007; Hurley 
and Edenberg, 2012; Thomasson et al., 1993), is assumed to 
produce aversive effects, leading to lower alcohol consump-
tion. However, no study has formally examined the role of 
alcohol consumption in this set of relationships. Because 
ADH1B has previously been demonstrated to be related to 
alcohol consumption (Bierut et al., 2012; Hasin et al., 2002a; 
Meyers et al., 2013; Spivak et al., 2007), and there is con-
siderable overlap between the genetic infl uences on alcohol 
consumption and AUDs (Grant et al., 2009; Kendler et al., 
2010), here we formally test whether and to what extent the 
ADH1B relationship to AUDs is explained by its effect on 
alcohol consumption.
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 An additional consideration is that AUDs are diagnosed 
according to a set of 11 dependence or abuse criteria in the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSM-IV; American Psychiatric Association, 1994). 
To better understand the effects of ADH1B on AUDs, the 
relationship of ADH1B to each individual criterion should 
be determined. Although previous studies examined the as-
sociation between rs1229984 and AUDs in an Israeli sample 
(Meyers et al., 2013), the present study aims to increase our 
understanding of ADH1B effects in this sample by determin-
ing which of the AUD criteria underlie the association of 
rs1229984 with AUDs and whether an indicator of maximum 
alcohol consumption mediates these relationships. A previous 
study assessing the relationship between ADH1B SNPs and 
alcohol dependence phenotypes such as “severe use” and 
“withdrawal” (Gizer et al., 2011) found signifi cant evidence 
of an association with withdrawal symptoms. However, to our 
knowledge, no study has evaluated the relationship between 
ADH1B and each of the DSM-IV alcohol dependence or 
abuse criteria separately and whether these relationships are 
explained by the ADH1B effect on consumption.
 To address these issues, we fi rst examined the effect of 
ADH1B rs1229984 on the risk for lifetime AUDs through 
its effects on consumption. Second, we evaluated the effects 
of ADH1B on each of the DSM-IV lifetime AUD criteria. 
Third, for those criteria signifi cantly associated with ADH1B, 
we assessed whether ADH1B acted on these criteria through 
alcohol consumption. This study used data from a large general 
population sample of Israeli Jews (Shmulewitz et al., 2010, 
2012), where we previously showed a strong association 
between ADH1B and other alcohol phenotypes including 




 Data were collected in 2007–2009 from 1,349 Jewish 
adult household residents, as described in detail previously 
(Hasin et al., 2002a, 2002b; Shmulewitz et al., 2010, 2012). 
The sample was designed to investigate environmental and 
genetic infl uences on alcohol-related traits. Adult residents 
of Jewish ethnicity were selected from the Israeli Population 
Register by the Israeli Bureau of the Census. The Israeli 
Population Register comprises household residents in all 
areas of Israel; potential respondents were selected from 
the registry based on their demographic characteristics and 
to provide diversity in their area of residence. Men were 
oversampled, as drinking among Israeli women is limited 
(Shmulewitz et al., 2010). Participants of Jewish ethnicity 
were selected to provide sample homogeneity for the genetic 
research questions.
 Interviewers received structured training and administered 
face-to-face computer-assisted interviews after obtaining writ-
ten informed consent, as approved by relevant American and 
Israeli institutional review boards (Shmulewitz et al., 2010). 
Interviews were administered in Hebrew or Russian. As de-
scribed previously (Hasin et al., 2002a, 2002b; Shmulewitz 
et al., 2012; Spivak et al., 2007), translation of the interview 
followed standard translation–back translation procedures in 
use by the World Health Organization, with extensive col-
laboration between Americans and Israelis fl uent in Hebrew, 
Russian, and English. The overall response rate was 68.9%. 
Quality control included fi eld observation, reviews of recorded 
interviews, and telephone verifi cation of responses.
Sample
 The present analysis is based on 1,130 ever-drinkers 
(respondents who reported at least one sip of alcohol, life-
time) after excluding respondents who (a) did not provide 
information on drinking (n = 2), (b) were never exposed to 
alcohol (n = 67), or (c) were ever-drinkers but were missing 
genotypes for the ADH1B SNP rs1229984 (n = 150). Based 
on previous work in this sample (Hasin et al., 2002a, 2002b; 
Shmulewitz et al., 2012; Spivak et al., 2007), demographic 
covariates associated with alcohol-related phenotypes were 
age, sex, and emigration from the former Soviet Union 
(FSU). Of those participating, 25.1% (n = 284) were 21–29 
years old, 33.6% (n = 380) were 30–44, and 41.2% (n = 466) 
were 45 or older; 78.3% (n = 885) were male; and 23.9% (n 
= 270) were emigrants from the FSU.
Measures
 DSM-IV alcohol use disorder and criteria. The Alcohol 
Use Disorders and Associated Disabilities Interview Sched-
ule (AUDADIS; Grant et al., 1995, 2003) was used to assess 
the alcohol abuse and dependence criteria following DSM-
IV guidelines (American Psychiatric Association, 1994). 
Binary variables were created for each of the seven alcohol 
dependence criteria (tolerance: diminished effect with same 
quantity or need more to get desired effect; larger/longer: 
drinking more or for longer periods than intended; quit/
control: inability to quit despite attempts or desire to stop/
drink less; time spent: excessive time spent obtaining, us-
ing, or recovering from alcohol; activities given up: giving 
up important activities to drink; withdrawal: evidence of the 
withdrawal syndrome or alcohol/other related substances 
taken to prevent/relieve symptoms; and physical/psychologi-
cal: continued drinking despite physical and/or psychological 
problems associated with use). Binary variables were simi-
larly created for the four alcohol abuse criteria (hazardous 
use: drinking in situations where it is physically hazardous 
to do so; social problems: drinking despite issues with social 
contacts resulting from alcohol use; neglect roles: drinking 
causing interferences with work, home, or school responsi-
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bilities; and legal problems: arrest or other legal problems 
associated with drinking).
 A binary variable was created for AUDs by combining 
diagnoses for lifetime alcohol dependence (three or more 
dependence criteria within a 12-month period) and alcohol 
abuse (one or more abuse criteria in the absence of lifetime 
alcohol dependence). Reliability and validity of AUDADIS-
IV alcohol diagnoses in clinical and general population 
samples, in U.S. and international studies, ranges from 
good to excellent (Chatterji et al., 1997; Grant et al., 1995, 
2003; Hasin et al., 1997). Reliability of DSM-IV criteria 
was similarly found to be good (majority of κ values exceed 
.60; Chatterji et al., 1997). The lifetime timeframe was used 
throughout (except for one sensitivity analysis) because ge-
netic effects could be missed if only the current timeframe 
was used.
 Alcohol consumption—Maxdrinks. Using the AUDADIS 
alcohol consumption measures, we created a variable indicat-
ing maximum number of drinks in a 24-hour period during 
period of heaviest drinking (Maxdrinks; Meyers et al., 2013; 
Shmulewitz et al., 2012), similar to the maximum drinks 
variable used previously in genetic studies (Dawson et al., 
2010; Greenfi eld et al., 2006; Malone et al., 2002; Saccone 
et al., 2000; Schuckit et al., 2002; Schumann et al., 2003; 
Shea et al., 2001; Spivak et al., 2007; Yang et al., 2005). AU-
DADIS consumption items have good psychometric proper-
ties and good to excellent interrater reliability (intraclass 
correlation coeffi cients for all consumption items = .59–.99; 
.70 for Maxdrinks specifi cally) and excellent validity (Grant 
et al., 1995, 2003; Hasin et al., 1997). Because the distribu-
tion of Maxdrinks was skewed (Meyers et al., 2013), for the 
mediation analysis, Maxdrinks was transformed to have a 
mean of 0 and standard deviation of 1.
 Genotyping. Genotyping procedures have been detailed 
elsewhere (Meyers et al., 2013). In brief, DNA was extracted 
from blood or saliva samples using standard techniques. 
The Sequenom MassArray (Sequenom, San Diego, CA) 
was used to genotype ADH1B SNP rs1229984; no evidence 
of deviation from Hardy–Weinberg equilibrium was found. 
Both genotype groups with the protective allele A (AA and 
AG) showed similar prevalences for DSM-IV alcohol crite-
ria; therefore, they were combined into one group. Higher 
criteria prevalences were found in those without allele A 
(genotype group GG). Thus, we defi ne “high risk” as the 
absence of allele A, leading to a group that constitutes 52.6% 
of our sample. We compare the genetically high-risk group 
to the low-risk group (genotypes AA or AG) in our analy-
ses. Ancestry-informative markers were included to assess 
population stratifi cation (Listman et al., 2010). Genotypes at 
rs1229984 were not associated with age, sex, or FSU status.
 Statistical analysis. Chi-square analysis evaluated differ-
ences in criterion prevalence by demographic subgroup.
 Regression analysis. Logistic regression (SAS Version 
9.2, SAS Institute Inc., Cary, NC) assessed association of 
the rs1229984 high-risk group with each phenotype (AUDs 
and each alcohol abuse or dependence criterion). Analyses 
were adjusted for sex, age, and FSU status, because drink-
ing behavior differs by these subgroups in Israel (Hasin et 
al., 2002b; Shmulewitz et al., 2012; Spivak et al., 2007). 
Results are reported as odds ratios (OR), the exponential of 
the regression coeffi cient τ, indicating the increase in the 
odds of the phenotype in the high-risk group. For each phe-
notype signifi cantly associated with ADH1B, two additional 
regressions were performed to evaluate the effect through 
Maxdrinks (Baron and Kenny, 1986): (a) Maxdrinks was 
regressed on ADH1B (regression coeffi cient = α); (b) each 
phenotype was regressed on ADH1B with Maxdrinks in the 
model (regression coeffi cient for Maxdrinks = β; for ADH1B 
= τ′; Figure 1). The effect of ADH1B through Maxdrinks was 
calculated as αβ (“product of the coeffi cients” (Sobel, 1982; 
Figure 1), with a signifi cant effect indicated by αβ  signifi -
cantly greater than 0. To determine the signifi cance of αβ, 
we created 1,000 bootstrapped samples to generate empiri-
cal percentile confi dence intervals (CIs) and p values since 
the distribution of αβ for nonnormal outcomes is unknown 
(Bollen and Stine, 1990; Shrout and Bolger, 2002). Empiri-
cal 95% CIs were computed by ordering the αβ values from 
the bootstrapped samples from lowest to highest; the 25th 
value represents the lower bound (2.5%), and the 975th 
value represents the upper bound (97.5%). P values were the 
percentage of bootstrapped samples with αβ of 0 or less.
 The percentage of the ADH1B effect explained by 
Maxdrinks was calculated as follows: {[exp(τ) − exp(τ′)] / 
[exp(τ) − 1]} × 100, where exp(τ) is the OR for the ADH1B 
effect without Maxdrinks in the model (Model A), and 
exp(τ′) is the OR with Maxdrinks in the model (Model B) 
(Shmulewitz et al., 2012). When there is no effect—that is, 
the OR for the ADH1B effect is the same in both regression 
models [exp(τ) = exp(τ′)]—this equation evaluates to 0%. 
When there is no remaining ADH1B effect with Maxdrinks 
included in the model [exp(τ′) = 1], this equation evaluates 
FIGURE 1. Path diagram for Model A, the total effect (τ) of ADH1B on 
drinking phenotypes, and model B, the direct (τ′) and indirect (through the 
Maxdrinks; αβ) effect of ADH1B on drinking phenotypes. Note: Alcohol 
phenotype refers to each criterion or any alcohol use disorder.
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to 100%. Empirical CIs and p values were calculated for this 
percentage.
 Exploratory analysis. To further explore the association 
of ADH1B with AUDs and the individual AUD criteria, a 
latent variable model was examined using Mplus Version 
6.12. In this model, the association between ADH1B and an 
AUD latent variable, indexed by the 11 criteria, was exam-
ined, in addition to simultaneous logistic regressions of each 
individual criterion and ADH1B. Control variables (age, sex, 
FSU status) were also included in this model.
Results
 The overall prevalence of the abuse or dependence criteria 
ranged from 1.9% to 34.2% (Table 1). The most commonly 
endorsed dependence criterion was drinking more or over 
longer periods than intended (larger/longer; 34.2%), and 
the most commonly endorsed abuse criterion was drinking 
in situations where it is physically hazardous to do so (haz-
ardous use; 16.8%). Men were signifi cantly more likely to 
endorse all criteria except neglect of major roles and legal 
problems (Table 1). Younger individuals were signifi cantly 
more likely to endorse hazardous use, drinking despite social 
problems, and all dependence criteria except activities given 
up (Table 1). FSU emigrants were more likely to endorse 
larger/longer, activities given up, continued drinking despite 
physical and/or psychological problems associated with use 
(physical/psychological), and all abuse criteria except neglect 
roles (Table 1).
ADH1B, alcohol use disorders, and individual criteria
 A higher prevalence of AUDs, as well as dependence and 
abuse criteria, was observed among the high-risk genotype 
group (Table 2). Prevalence values ranged from 2.4% to 39.6% 
and from 2.2% to 19.7% for dependence and abuse criteria, 
respectively (Table 2). After adjusting for demographic vari-
ables, ADH1B-rs1229984 was signifi cantly associated with 
AUDs (OR = 1.77), as previously demonstrated for this popu-
lation (Meyers et al., 2013). It was also signifi cantly associated 
with 6 of the 11 criteria (Model A in Table 3): Individuals in 
the high-risk group had higher odds of endorsing tolerance 
(OR = 1.32), quit/control (OR = 1.45), larger/longer (OR = 
1.75), physical/psychological (OR = 1.96), hazardous use 
(OR = 1.59), and social problems (OR = 1.63).
Effects mediated through Maxdrinks
 In Model B (with Maxdrinks; Figure 1), the direct effect 
of ADH1B (τ′) on AUDs and each associated criterion was 
less than in Model A (τ; Table 3), suggesting an effect that 
is at least partially mediated through Maxdrinks. The effect 
through Maxdrinks is depicted in regression Model B, where 
ADH1B signifi cantly predicted higher Maxdrinks (α = .23), 
and Maxdrinks signifi cantly predicted AUDs and each of 
the six associated criteria (β; Table 3). Thus, for each phe-
notype, αβ was signifi cantly greater than 0, indicating that 
part of the ADH1B effect is through its effects on Maxdrinks 
(Table 3). The percentage of the ADH1B effect explained by 
Maxdrinks was sizeable for AUDs (43.7%), larger/longer 
(34.6%), and physical/psychological (22.9%), but signifi cant 
association remained with ADH1B even with Maxdrinks in 
the model. In contrast, for the other four criteria (tolerance 
[74.4% of the ADH1B effect due to Maxdrinks], quit/con-
trol [39.2%], hazardous use [46.6%], and social problems 
[45.1%]), the relationship with ADH1B was no longer sig-
nifi cant with Maxdrinks in the model.
Exploratory analysis
 In the exploratory analysis modeling AUD as a latent 
variable and regressing the AUD variable and the indi-
TABLE 1. Prevalence of DSM-IV alcohol abuse/dependence criteria and relationship to demographic variables
 Overall
 prevalence, % %  % % %  % %
Criterion % men women χ2 20–29 30–44 ≥45 χ2 FSU non-FSU χ2
Alcohol dependence
 Tolerance 33.2 37.0 19.6 26.07**** 55.0 33.4 19.7 95.55**** 33.0 33.3 0.01
 Quit/control 12.5 14.2 6.1 11.57* 18.0 12.9 8.8 13.65* 13.7 12.1 0.49
 Larger/longer 34.2 38.0 20.4 26.30**** 50.0 35.8 23.2 57.13**** 40.4 32.2 6.09*
 Time spent 10.4 11.9 4.9 10.03* 16.9 9.2 7.3 18.85* 9.6 10.6 0.20
 Activities given up 2.0 2.4 0.4 3.88* 1.8 2.6 1.5 1.47 4.1 1.3 8.41*
 Withdrawal 14.7 16.6 7.8 12.01* 23.6 15.8 8.4 33.18**** 17.0 14.0 1.56
 Physical/psychological 10.9 13.0 3.3 18.72**** 15.5 12.1 7.1 13.75* 20.0 8.0 30.39****
Alcohol abuse
 Neglect roles 2.6 3.1 0.8 3.83 4.2 2.6 1.5 5.24 4.1 2.1 3.23
 Hazardous use 16.8 20.2 4.5 33.97**** 23.9 18.7 10.9 22.75**** 25.2 14.2 17.77****
 Social problems 8.6 10.6 1.2 21.59**** 16.9 6.3 5.4 33.68**** 17.4 5.8 35.20****
 Legal problems 1.9 2.3 0.4 3.61 2.8 2.2 0.8 4.02 5.9 0.6 32.18****
Notes: DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; FSU = emigrant from the former Soviet Union.
*p < .05; ****p ≤ .0001.
FSU statusSex Age, in years
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TABLE 2. Relationship between any alcohol use disorder (AUD)/alcohol criteria and ADH1B-
rs1229984 among ever-drinkers (N = 1,130)
 Prevalencea
 High-risk group Low-risk group
Phenotype (GG; n = 594) (AA/AG; n = 536) Wald χ2,b
Any AUD 29.6 20.2 13.46***
Alcohol dependence
 Tolerance 35.7 30.4 4.32*
 Quit/control 14.3 10.5 3.96*
 Larger/longer 39.6 28.2 17.54***
 Time spent 11.6 9.0 2.24
 Activities given up 2.4 1.5 1.04
 Withdrawal 15.3 14.0 0.43
 Physical/psychological 13.8 7.7 10.52**
Alcohol abuse
 Neglect roles 3.03 2.1 0.96
 Hazardous use 19.7 13.6 7.49**
 Social problems 10.4 6.5 4.49*
 Legal problems 2.2 1.5 0.28
aFrom cross-tabulation; bfrom logistic regression adjusted for age, sex, emigrant from former 
Soviet Union status.
*p < .05; **p < .01; ***p < .001.
TABLE 3. Relationship between ADH1B-rs1229984 risk status and AUDs/alcohol criteria: without Maxdrinks (Model A) and with Maxdrinks (Model B) in 
the regression models
 Model B Maxdrinks included
    Indirect effect of
  Direct ADH1B effect Maxdrinks effect ADH1B on alcohol % of ADH1B effect
 ADH1B effect on the on the alcohol on the alcohol phenotype through explained by
 alcohol phenotype (τ) phenotype (τ′) phenotype (β) Maxdrinks Maxdrinks
Criterion ORa [95% CI] ORa [95% CI] ORa [95% CI] αβ [95% CI]b % [95% CI]b
Any alcohol use disorder 1.77 [1.32, 2.37]**** 1.45 [1.05, 2.00]* 2.94 [2.38, 3.64]**** 0.25 [0.14, 0.40]*** 43.7 [15.6, 80.8]***
Alcohol dependence
 Tolerance 1.32 [1.02, 1.73]* 1.08 [0.82, 1.44] 2.67 [2.16, 3.28]**** 0.23 [0.12, 0.37]*** 74.4 [23.2, 100.0]*
 Quit/control 1.45 [1.01, 2.08]* 1.27 [0.87, 1.85] 1.60 [1.37, 1.86]**** 0.11 [0.06, 0.17]*** 39.2 [5.8, 100.0]*
 Larger/longer 1.75 [1.35, 2.27]**** 1.49 [1.13, 1.97]** 2.58 [2.10, 3.16]**** 0.22 [0.12, 0.36]*** 34.6 [15.3, 66.5]***
 Time spent 1.35 [0.91, 2.00] .        – .        – .        – .        –
 Activities given up 1.58 [0.65, 3.84] .        – .        – .        – .        –
 Physical/psychological 1.96 [1.31, 2.95]** 1.74 [1.15, 2.65]** 1.55 [1.33, 1.81]**** 0.10 [0.05, 0.16]*** 22.9 [5.8, 58.0]**
 Withdrawal 1.12 [0.80, 1.57] .        – .        – .        – .        –
Alcohol abuse
 Neglect roles 1.47 [0.68, 3.15] .        – .        – .        – .        –
 Hazardous use 1.59 [1.14, 2.21]** 1.31 [0.92, 1.87] 2.20 [1.83, 2.65]**** 0.18 [0.10, 0.30]*** 46.6 [14.1, 100.0]**
 Social problems 1.63 [1.04, 2.57]* 1.35 [0.83, 2.18] 1.89 [1.59, 2.26]**** 0.15 [0.08, 0.24]*** 45.1 [0.0, 100.0]*
 Legal problems 1.28 [0.51, 3.18] .        – .        – .        – .        –
Notes: ADH1B effect on Maxdrinks α [95% CI]: 0.23 [0.13, 0.34], p < .0001. aOR = odds ratio, from logistic regression adjusted for sex, age, emigrant from 
former Soviet Union status: the exponential of the corresponding regression coeffi cients τ, τ′, or β (Figure 1); bempirical percentile confi dence interval from 
1,000 bootstrapped samples.




vidual criteria on ADH1B, ADH1B was not signifi cantly 
associated with the AUD latent variable (regression coef-
fi cient = -.061, 95% CI [-.25, .12], p = .521), whereas 
the associations between ADH1B and the individual cri-
teria were similar to those in the main analysis (presented 
above and in Table 3). For example, the same six criteria 
were signifi cantly associated with ADH1B: tolerance (OR 
= 1.64, 95% CI [1.02, 2.64]), quit/control (OR = 1.64, 
95% CI [1.01, 2.66]), larger/longer (OR = 2.72, 95% CI 
[1.59, 4.67]), physical/psychological (OR = 2.50, 95% CI 
[1.41, 4.45]), hazardous use (OR = 1.89, 95% CI [1.16, 
3.08]), and social problems (OR = 2.23, 95% CI [1.05, 
4.76]).
Discussion
 In this study, we found that ADH1B-rs1229984 was re-
lated to AUDs and six individual DSM-IV AUD criteria in an 
Israeli household sample. A signifi cant portion of the effect 
acts through Maxdrinks, supporting the premise that ADH1B 
effects on AUD criteria and diagnosis occur through limiting 
excessive alcohol consumption.
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 Although previous studies found robust associations 
between AHD1B and AUDs in Asian (Li et al., 2011), 
European (Bierut et al., 2012), and Israeli samples (Hasin 
et al., 2002b; Meyers et al., 2013), this is the fi rst study to 
examine the association between ADH1B and each DSM-IV 
criterion individually. Our main results suggest that the as-
sociation between ADH1B and AUDs may be explained by 
the association of ADH1B with six criteria, further support-
ed by the results of our exploratory latent variable model. 
Although the low prevalence of certain criteria (i.e., activi-
ties given up, neglect roles, legal problems) may have led to 
low power for detecting signifi cant associations with these 
criteria, a recent twin study suggested that multiple genetic 
factors may be associated with the different dependence 
criteria (Kendler et al., 2012), supporting the possibility that 
other genetic factors infl uence the risk for the criteria that 
were unrelated to ADH1B in this sample. Studies in popula-
tions with substantially higher prevalence of these criteria 
(i.e., clinical samples, see Hasin et al., 2012) are needed to 
determine the relationship of these less frequent AUD crite-
ria to ADH1B.
 This is the fi rst study to formally test the long-held as-
sumption that the protective allele of ADH1B-rs1229984 in-
fl uences AUD risk by limiting alcohol consumption. We did 
this by showing that a substantial proportion of the ADH1B 
effect acts through consumption (Maxdrinks). Similarly, 
much of the ADH1B effect on the six associated DSM-IV 
AUD criteria acts through Maxdrinks. The remaining effect 
of ADH1B on AUDs (after accounting for mediation through 
Maxdrinks) may be attributable to the unobserved ADH1B 
effect on other criteria (as discussed above) or the remaining 
ADH1B effect on larger/longer and physical/psychological. 
For these criteria, other mechanisms may account for the 
remaining ADH1B effect, such as interaction with environ-
mental factors (i.e., stress; Keyes et al., 2012) or other ADH 
or neuronal genes, common to many externalizing disorders 
(i.e., GABRA2; Agrawal and Bierut, 2012).
 The analysis presented here used the Maxdrinks vari-
able to indicate alcohol consumption because subjective 
adverse effects of the alcohol metabolism process may 
limit the maximum quantity of alcohol a person can con-
sume. Other alcohol consumption variables could also have 
been used. As a post hoc sensitivity analysis, we used a 
variable, “usual drinks” (defi ned as the number of drinks 
a respondent usually had/has in a single day, during period 
of heaviest drinking), in place of Maxdrinks. Similar to 
Maxdrinks, usual drinks was related to ADH1B (regres-
sion coeffi cient = .21; 95% CI = [.07, .34], p = .0026), but 
usual drinks showed a weaker relationship to the alcohol 
phenotypes (any AUD, each AUD criterion). Therefore, the 
mediation effect for usual drinks was lower than for Max-
drinks. These results suggest that the Maxdrinks consump-
tion indicator better explains the relationship of ADH1B to 
alcohol phenotypes.
 Study limitations are noted. First, although gene as-
sociation studies are potentially confounded by population 
stratifi cation, a previous study in this sample (Meyers et al., 
2013) showed no confounding by population stratifi cation 
of the relationship between ADH1B and AUDs or Max-
drinks. Nevertheless, signifi cant associations of ADH1B 
with each alcohol criterion were re-analyzed adjusting for 
population substructure among participants with ancestry 
informative markers available (n = 1,096). Results were 
quite similar, although with slightly larger CIs and p values 
(most likely because of smaller sample size), indicating that 
the associations did not arise solely because of confounding 
by population substructure. Second, we may be detecting 
signifi cant signals from variants that are in linkage dis-
equilibrium with ADH1B-rs1229984. However, enzymatic 
studies show that this ADH1B variant is functional, affect-
ing enzyme kinetics (Bosron and Li, 1986; Bosron et al., 
1983), supporting ADH1B-rs1229984 as the possible causal 
variant. 
 A third limitation is that the cross-sectional nature of 
the sample might restrict our ability to determine the exact 
directionality of these associations. However, the direction 
modeled here is plausible. ADH1B is expressed once indi-
viduals begin drinking alcohol, so we only included those 
exposed to alcohol; thus, the ADH1B risk factor precedes 
both alcohol consumption and AUD development. Alcohol 
consumption must precede criterion endorsement and AUDs. 
To further address the temporality issue, a sensitivity analy-
sis was conducted addressing AUD and criteria occurring 
within the 12 months before the interview (i.e., a current 
timeframe). The results were very similar to the analysis 
reported, further suggesting that the temporality of the model 
is plausible. In the future, these issues should be addressed 
using longitudinal data. Fourth, the lack of evidence for sig-
nifi cant association between ADH1B and criteria with low 
prevalence (e.g., activities given up, neglect roles, and legal 
problems) may be attributable to low power, and the study 
should be repeated on a larger sample. However, this study 
remains informative about overall AUD and the criteria with 
higher prevalences. Last, because legal problems will be 
replaced by craving in DSM-5 (American Psychiatric Asso-
ciation, 2013), future studies should assess the relationship 
of ADH1B to alcohol craving, which was not available in this 
data set.
 In conclusion, this study provides new information on the 
associations between ADH1B and AUDs and the DSM-IV 
AUD criteria (including effects through alcohol consump-
tion), which enhances our understanding of the etiologic 
model through which AUDs can occur. For genetically com-
plex disorders (e.g., AUDs), where numerous genes exert 
small effects on the broad clinical phenotype, identifying 
which aspects (i.e., criteria) are most informative in the as-
sociation between ADH1B and AUDs advances our under-
standing of ADH1B effects.
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